GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
27. Mai 2024 10:31 ET
|
The Rosen Law Firm PA
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and...
ALT INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
09. Mai 2024 14:52 ET
|
The Rosen Law Firm PA
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...
Safety Pen Needles Market in North America to Exceed Value of US$ 1.17 Bn by 2031, States TMR Analysis
30. September 2022 09:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The safety pen needles market in North America is prognosticated to surpass a value of US$...